REFERENCES
1. Shen W-K, Sheldon RS, Benditt DG, et al. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope. A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society . 2017;70(5):e39-e110. doi:10.1016/j.jacc.2017.03.003
2. Brignole M, Moya A, de Lange FJ, et al. 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal . 2018;39(21):1883-1948. doi:10.1093/eurheartj/ehy037
3. Ruwald MH, Hansen ML, Lamberts M, et al. The relation between age, sex, comorbidity, and pharmacotherapy and the risk of syncope: a Danish nationwide study. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . Oct 2012;14(10):1506-14. doi:10.1093/europace/eus154
4. Sun BC, Emond JA, Camargo CA, Jr. Characteristics and admission patterns of patients presenting with syncope to U.S. emergency departments, 1992-2000. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine . Oct 2004;11(10):1029-34. doi:10.1197/j.aem.2004.05.032
5. Ruwald MH, Hansen ML, Lamberts M, et al. Accuracy of the ICD-10 discharge diagnosis for syncope. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . Apr 2013;15(4):595-600. doi:10.1093/europace/eus359
6. Olde Nordkamp LR, van Dijk N, Ganzeboom KS, et al. Syncope prevalence in the ED compared to general practice and population: a strong selection process. The American journal of emergency medicine . Mar 2009;27(3):271-9. doi:10.1016/j.ajem.2008.02.022
7. van Dijk N, Sprangers MA, Colman N, Boer KR, Wieling W, Linzer M. Clinical factors associated with quality of life in patients with transient loss of consciousness. Journal of cardiovascular electrophysiology . Sep 2006;17(9):998-1003. doi:10.1111/j.1540-8167.2006.00533.x
8. Sun BC. Quality-of-life, health service use, and costs associated with syncope. Progress in cardiovascular diseases . Jan-Feb 2013;55(4):370-5. doi:10.1016/j.pcad.2012.10.009
9. Linzer M, Pontinen M, Gold DT, Divine GW, Felder A, Brooks WB. Impairment of physical and psychosocial function in recurrent syncope.Journal of clinical epidemiology . 1991;44(10):1037-43.
10. Jorge JG, Raj SR, Teixeira PS, Teixeira JAC, Sheldon RS. Likelihood of injury due to vasovagal syncope: a systematic review and meta-analysis. EP Europace . 2021;23(7):1092-1099. doi:10.1093/europace/euab041 %J EP Europace
11. Sun BC, Emond JA, Camargo CA, Jr. Direct medical costs of syncope-related hospitalizations in the United States. The American journal of cardiology . Mar 1 2005;95(5):668-71. doi:10.1016/j.amjcard.2004.11.013
12. Aminorroaya A, Tavolinejad H, Sadeghian S, et al. Comparison of Outcomes with Midodrine and Fludrocortisone for Objective Recurrence in Treating Syncope (COMFORTS trial): Rationale and design for a multi-center randomized controlled trial. American Heart Journal . 2021/07/01/ 2021;237:5-12. doi:https://doi.org/10.1016/j.ahj.2021.03.002
13. Tavolinejad H, Poopak A, Sadeghian S, et al. Compression stockings for treating vasovagal syncope (COMFORTS-II) trial: Rationale and design of a triple-blind, multi-center, randomized controlled trial.American Heart Journal . 2022/07/01/ 2022;249:57-65. doi:https://doi.org/10.1016/j.ahj.2022.04.002
14. Benditt DG, Ermis C, Padanilam B, Samniah N, Sakaguchi S. Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . Jan 2003;5(1):65-70.
15. Goldstein DS, Holmes C, Frank SM, et al. Sympathoadrenal imbalance before neurocardiogenic syncope. The American journal of cardiology . Jan 1 2003;91(1):53-8.
16. Alboni P, Dinelli M, Gruppillo P, et al. Haemodynamic changes early in prodromal symptoms of vasovagal syncope. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . Jul 2002;4(3):333-8.
17. Olgunturk R, Turan L, Tunaoglu FS, et al. Abnormality of the left ventricular sympathetic nervous function assessed by I-123 metaiodobenzylguanidine imaging in pediatric patients with neurocardiogenic syncope. Pacing and clinical electrophysiology : PACE . Oct 2003;26(10):1926-30.
18. Vanderheyden M, Goethals M, Nellens P, Andries E, Brugada P. Different humoral responses during head-up tilt testing among patients with neurocardiogenic syncope. Am Heart J . Jan 1998;135(1):67-73.
19. Sra JS, Murthy V, Natale A, et al. Circulatory and catecholamine changes during head-up tilt testing in neurocardiogenic (vasovagal) syncope. The American journal of cardiology . Jan 1 1994;73(1):33-7.
20. Richard Harvey DF. Lippincott’s Illustrated Reviews: Biochemistry . fifth ed. 2011.
21. Huotari M, Gogos JA, Karayiorgou M, et al. Brain catecholamine metabolism in catechol-O-methyltransferase (COMT)-deficient mice.The European journal of neuroscience . Jan 2002;15(2):246-56.
22. Oner T, Guven B, Tavli V, Mese T, Yilmazer MM, Demirpence S. Postural Orthostatic Tachycardia Syndrome (POTS) and Vitamin B-12 Deficiency in Adolescents. Pediatrics . Jan 2014;133(1):E138-E142. doi:10.1542/peds.2012-3427
23. Pektas A, Koken R, Koca HB. Serum vitamin B-12 in children presenting with vasovagal syncope. Article. Asia Pacific Journal of Clinical Nutrition . 2018;27(1):176-181. doi:10.6133/apjcn.022017.17
24. Parekh S, Sastry B, Narasimhan C, Arora HJJC. To study vitamin B12 deficiency and response to treatment in patients presenting with vasovagal syncope. 2018;2(5):000134.
25. Sadeghian S, Aminorroaya A, Tajdini M. The Syncope Unit of Tehran Heart Center. European Heart Journal . 2020;42(2):148-150. doi:10.1093/eurheartj/ehaa532 %J European Heart Journal
26. Poorhosseini H, Abbasi SH. The Tehran Heart Center. European Heart Journal . 2018;39(29):2695-2696. doi:10.1093/eurheartj/ehy369 %J European Heart Journal
27. Shafiee A, Saadat S, Shahmansouri N, et al. Tehran cohort study (TeCS) on cardiovascular diseases, injury, and mental health: Design, methods, and recruitment data. Global Epidemiology . 2021/11/01/ 2021;3:100051. doi:https://doi.org/10.1016/j.gloepi.2021.100051
28. Bartoletti A, Alboni P, Ammirati F, et al. ’The Italian Protocol’: a simplified head-up tilt testing potentiated with oral nitroglycerin to assess patients with unexplained syncope. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology . Oct 2000;2(4):339-42. doi:10.1053/eupc.2000.0125
29. Brignole M, Menozzi C, Del Rosso A, et al. New classification of haemodynamics of vasovagal syncope: beyond the VASIS classificationAnalysis of the pre-syncopal phase of the tilt test without and with nitroglycerin challenge. EP Europace . 2000;2(1):66-76. doi:10.1053/eupc.1999.0064
30. Tajdini M, Aminorroaya A, Tavolinejad H, et al. Atomoxetine as an adjunct to nonpharmacological treatments for preventing vasovagal attacks in patients with recurrent vasovagal syncope: A pilot randomized-controlled trial. IJC Heart & Vasculature . 2021/06/01/ 2021;34:100789. doi:https://doi.org/10.1016/j.ijcha.2021.100789
31. Iwase S, Nishimura N, Mano T. Role of sympathetic nerve activity in the process of fainting. Front Physiol . 2014;5:343-343. doi:10.3389/fphys.2014.00343
32. Sharada K, Reddy G, Narasimhan C. Cobalamin deficiency presenting as refractory vaso vagal syncope. Letter. International Journal of Cardiology . 2012;156(1):e7-e8. doi:10.1016/j.ijcard.2011.07.093
33. Ghaznain M, Donnelly TM, Halpenny L. Tilt table test outcome in the diagnosis and prevalence of syncope in patients with vitamin d and vitamin B12 deficiency. Age and Ageing . Sep 2017;46doi:10.1093/ageing/afx144.60
34. Aysin E, Urhan M. Dramatic Increase in Dietary Supplement Use During Covid-19. Current Developments in Nutrition . 2021;5(Supplement_2):207-207. doi:10.1093/cdn/nzab029_008 %J Current Developments in Nutrition
35. Çimke S, Yıldırım Gürkan D. Determination of interest in vitamin use during COVID-19 pandemic using Google Trends data: Infodemiology study.Nutrition . 2021;85:111138-111138. doi:10.1016/j.nut.2020.111138
36. Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. 2021;11(3):e045343. doi:10.1136/bmjopen-2020-045343 %J BMJ Open
37. Oh R, Brown DL. Vitamin B12 deficiency. American family physician . Mar 1 2003;67(5):979-86.